Skip to content
Medical Health Aged Care

KFSHRC’s Study Named Among Top 10 Most Impactful Papers of 2024

King Faisal Specialist Hospital & Research Centre 2 mins read

research 2025 -8

RIYADH, Saudia Arabia, Jan. 09, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has solidified its reputation as a global leader in medical innovation with its study on fully robotic liver transplants recognized as one of the Top 10 Most Impactful Papers of 2024 by the American Society of Transplantation. 

Building on KFSHRC’s legacy of breakthroughs, the study, ‘Outcomes of Fully Robotic Recipient Living Donor Liver Transplant about the Open Approach,’ represents the world’s first series of fully robotic recipient liver transplants from living donors. The paper highlighted significant advancements in robotic-assisted liver transplantation, including significantly reduced blood loss, shorter hospital stays, and improved cosmetic outcomes compared to traditional open surgery. Importantly, these outcomes were achieved without increasing complication rates, reinforcing KFSHRC’s leadership in setting new surgical innovation and patient care benchmarks.

At the heart of this accomplishment is Professor Dr. Dieter Broering, The Executive Director of the Organ Transplant Centre of Excellence at KFSHRC. A globally recognized leader in robotic-assisted surgeries, Dr. Broering spearheaded in 2024 the world’s first fully robotic left lobe liver transplant. “This achievement highlights the transformative potential of robotic transplant, particularly for procedures previously considered high-risk, and reaffirms our dedication to delivering safer, faster, and more effective outcomes for patients worldwide,” Dr. Broering stated, reflecting on this recognition.

The study was published in the Transplantation Journal, the official monthly publication of The Transplantation Society. With over 58 years of history and over 25,000 annual citations, the journal is a vital platform for pioneering research.

It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 20th globally in the list of the world’s top 250 Academic Medical Centres for the second consecutive year and has been recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, it was included in the World’s Best Smart Hospitals list for 2025 by Newsweek magazine.

For more information, visit www.kfshrc.edu.sa or contact our media team at [email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/9d4dc3e0-976d-4931-b569-01dd87ed0bea


Primary Logo

More from this category

  • Medical Health Aged Care
  • 07/12/2025
  • 01:41
Takeda Pharmaceutical Company Limited

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline NEWARK,…

  • Medical Health Aged Care
  • 06/12/2025
  • 02:11
Arthur D. Little

Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation

NEW YORK–BUSINESS WIRE– Arthur D. Little (ADL) and Vega IT today announced the formation of Axceler8 Solutions, a 50/50 joint venture created to design,…

  • Contains:
  • Medical Health Aged Care, Women
  • 05/12/2025
  • 10:11
Breast Cancer Trials

Bec’s Christmas wish amid cancer treatment

This Christmas, Bec’s wish is for her daughters to never face a breast cancer diagnosis like she has. “The only thing tougher than telling…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.